Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts Novelty Seeking and Harm Avoidance

Mounting evidence from animal studies show that the mesolimbic dopaminergic pathways are modulated by the brain-derived neurotrophic factor (BDNF). This study investigates in N=768 healthy Caucasian participants the influence of two prominent functional single-nucleotide polymorphisms (SNPs) on the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Montag, Christian (VerfasserIn) , Markett, Sebastian (VerfasserIn) , Basten, Ulrike (VerfasserIn) , Stelzel, Christine (VerfasserIn) , Fiebach, Christian (VerfasserIn) , Canli, Turhan (VerfasserIn) , Reuter, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 April 2010
In: Neuropsychopharmacology
Year: 2010, Jahrgang: 35, Heft: 9, Pages: 1860-1867
ISSN:1740-634X
DOI:10.1038/npp.2010.55
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/npp.2010.55
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/npp201055
Volltext
Verfasserangaben:Christian Montag, Sebastian Markett, Ulrike Basten, Christine Stelzel, Christian Fiebach, Turhan Canli and Martin Reuter
Beschreibung
Zusammenfassung:Mounting evidence from animal studies show that the mesolimbic dopaminergic pathways are modulated by the brain-derived neurotrophic factor (BDNF). This study investigates in N=768 healthy Caucasian participants the influence of two prominent functional single-nucleotide polymorphisms (SNPs) on the BDNF gene (BDNF Val66Met SNP) and the ankyrin repeat and kinase domain containing 1 (ANKK1) gene (DRD2 Taq Ia/ANKK1 SNP) on the personality traits of Novelty Seeking and Harm Avoidance, which are mediated, in part, through dopaminergic mesolimbic circuitry. Carriers of the 66Met+/A1+ variant scored lowest on Novelty Seeking and highest on Harm Avoidance, compared to all other genotype groups. These participants are characterized by a relatively low D2 receptor density in the striatum and an impaired activity-dependent secretion of BDNF. This is one of the first genetic association studies to show a modulatory role for BDNF genetic variation on genetically mediated differences in the mesolimbic dopaminergic system in the context of human personality.
Beschreibung:Gesehen am 03.05.2023
Beschreibung:Online Resource
ISSN:1740-634X
DOI:10.1038/npp.2010.55